Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Recombinant Plasma Protein Therapeutics
The 2025-2030 World Outlook for Recombinant Plasma Protein Therapeutics This study covers the world outlook for recombinant plasma protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics
The 2025-2030 World Outlook for Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics This study covers the world outlook for acute lymphocytic-lymphoblastic leukemia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ... Read More
-
The 2025-2030 World Outlook for Drug Discovery Informatics
The 2025-2030 World Outlook for Drug Discovery Informatics This study covers the world outlook for drug discovery informatics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Dilated Cardiomyopathy Therapeutics
The 2025-2030 World Outlook for Dilated Cardiomyopathy Therapeutics This study covers the world outlook for dilated cardiomyopathy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Pneumonia Therapeutic Drugs
The 2025-2030 World Outlook for Pneumonia Therapeutic Drugs This study covers the world outlook for pneumonia therapeutic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Sexually Transmitted Diseases (STDs) Drugs
The 2025-2030 World Outlook for Sexually Transmitted Diseases (STDs) Drugs This study covers the world outlook for sexually transmitted diseases (STDs) drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments
The 2025-2030 World Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments This study covers the world outlook for non-Hodgkin's lymphoma and chronic lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Fragment-Based Drug Discovery
The 2025-2030 World Outlook for Fragment-Based Drug Discovery This study covers the world outlook for fragment-based drug discovery across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics This study covers the world outlook for non-Hodgkin lymphoma chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I ... Read More
-
The 2025-2030 World Outlook for Disease Care Management Solutions
The 2025-2030 World Outlook for Disease Care Management Solutions This study covers the world outlook for disease care management solutions across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Lymphoma Therapeutics
The 2025-2030 World Outlook for Lymphoma Therapeutics This study covers the world outlook for lymphoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Sexual Dysfunction Drugs
The 2025-2030 World Outlook for Sexual Dysfunction Drugs This study covers the world outlook for sexual dysfunction drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Drug Discovery and Development RNA Interference (RNAi)
The 2025-2030 World Outlook for Drug Discovery and Development RNA Interference (RNAi) This study covers the world outlook for drug discovery and development RNA interference (RNAi) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Immunology
The 2025-2030 World Outlook for Immunology This study covers the world outlook for immunology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the per ... Read More
-
The 2025-2030 World Outlook for Narcolepsy Therapeutics
The 2025-2030 World Outlook for Narcolepsy Therapeutics This study covers the world outlook for narcolepsy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for NASH (Non-Alcoholic Steatohepatitis) Biomarkers
The 2025-2030 World Outlook for NASH (Non-Alcoholic Steatohepatitis) Biomarkers This study covers the world outlook for NASH (non-alcoholic steatohepatitis) biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Viral Conjunctivitis Pipeline Drugs
The 2025-2030 World Outlook for Viral Conjunctivitis Pipeline Drugs This study covers the world outlook for viral conjunctivitis pipeline drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Parkinson's Disease Therapeutics
The 2025-2030 World Outlook for Parkinson's Disease Therapeutics This study covers the world outlook for Parkinson's disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Liver Cancer Therapeutics
The 2025-2030 World Outlook for Liver Cancer Therapeutics This study covers the world outlook for liver cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Progressive Multifocal Leukoencephalopathy Treatments
The 2025-2030 World Outlook for Progressive Multifocal Leukoencephalopathy Treatments This study covers the world outlook for progressive multifocal leukoencephalopathy treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Therapeutics
The 2025-2030 World Outlook for Breast Cancer Therapeutics This study covers the world outlook for breast cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Exocrine Pancreatic Insufficiency Therapeutics
The 2025-2030 World Outlook for Exocrine Pancreatic Insufficiency Therapeutics This study covers the world outlook for exocrine pancreatic insufficiency therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I ... Read More
-
The 2025-2030 World Outlook for Exosome Diagnostic and Therapeutics
The 2025-2030 World Outlook for Exosome Diagnostic and Therapeutics This study covers the world outlook for exosome diagnostic and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Rare Disease Drugs
The 2025-2030 World Outlook for Rare Disease Drugs This study covers the world outlook for rare disease drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Peptic Ulcer Drugs
The 2025-2030 World Outlook for Peptic Ulcer Drugs This study covers the world outlook for peptic ulcer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
Research Assistance
